Literature DB >> 17061122

WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.

Katsuyoshi Kanemoto1, Kenji Ishikura, Daisuke Ariyasu, Yuko Hamasaki, Hiroshi Hataya, Yukihiro Hasegawa, Masahiro Ikeda.   

Abstract

The Wilms' tumor suppressor gene (WT1) plays crucial roles in urogenital and gonadal development. Germline mutations of WT1 have been reported in patients with Denys-Drash syndrome (DDS) and Frasier syndrome (FS). Based on clinical overlaps reported to date, it has been suggested that these two syndromes should be considered as part of a spectrum of diseases caused by WT1 gene mutations, rather than as separate diseases. We report a new mutation in an intron 9 splice acceptor site (IVS -1G-->) in a Japanese 46,XY male patient with focal segmental glomerulosclerosis (FSGS) and bilateral cryptorchism. The clinical phenotype of this patient resembled FS without male pseudohermaphroditism. Interestingly, although the patient's right kidney was diagnosed with FSGS, his left kidney showed severe hypoplasia. There are no previous case reports of FSGS and renal hypoplasia in the same individual with a WT1 mutation. The findings for this case further suggest that the renal phenotype has various manifestations and is not always decided by the type of WT1 mutation. The possibility that the position of the WT1 mutation may influence the course of the nephropathy should be evaluated in a larger patient cohort.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061122     DOI: 10.1007/s00467-006-0333-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis.

Authors:  E Denamur; N Bocquet; V Baudouin; F Da Silva; R Veitia; M Peuchmaur; J Elion; M C Gubler; M Fellous; P Niaudet; C Loirat
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

2.  Clinical spectrum of Denys-Drash and Frasier syndrome.

Authors:  S J McTaggart; E Algar; C W Chow; H R Powell; C L Jones
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

3.  Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.

Authors:  E Denamur; N Bocquet; B Mougenot; F Da Silva; L Martinat; C Loirat; J Elion; A Bensman; P M Ronco
Journal:  J Am Soc Nephrol       Date:  1999-10       Impact factor: 10.121

Review 4.  Chronic renal failure and XY gonadal dysgenesis: "Frasier" syndrome--a commentary on reported cases.

Authors:  A V Moorthy; R W Chesney; M Lubinsky
Journal:  Am J Med Genet Suppl       Date:  1987

5.  Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?

Authors:  H Kikuchi; A Takata; Y Akasaka; R Fukuzawa; H Yoneyama; Y Kurosawa; M Honda; Y Kamiyama; J Hata
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

6.  WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes.

Authors:  Filippo Aucella; Luigi Bisceglia; Patrizia De Bonis; Maddalena Gigante; Gianluca Caridi; Giancarlo Barbano; Gerolamo Mattioli; Francesco Perfumo; Loreto Gesualdo; Gian Marco Ghiggeri
Journal:  Pediatr Nephrol       Date:  2006-08-15       Impact factor: 3.714

7.  Mutation analysis of the WT1 gene in sporadic childhood leukaemia.

Authors:  E Algar; D Blackburn; T Kromykh; G Taylor; P Smith
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

8.  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.

Authors:  C Jeanpierre; E Denamur; I Henry; M O Cabanis; S Luce; A Cécille; J Elion; M Peuchmaur; C Loirat; P Niaudet; M C Gubler; C Junien
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

9.  Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome.

Authors:  Rainer G Ruf; Michael Schultheiss; Anne Lichtenberger; Stephanie M Karle; Isabella Zalewski; Bettina Mucha; Anne Schulze Everding; Thomas Neuhaus; Ludwig Patzer; Christian Plank; Johannes P Haas; Fatih Ozaltin; Anita Imm; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

10.  46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation.

Authors:  Toshihiro Tajima; Satoshi Sasaki; Yayoi Tanaka; Hiroyuki Kusunoki; Testuro Nagashima; Katsuya Nonomura; Kenji Fujieda
Journal:  Horm Res       Date:  2003
View more
  2 in total

1.  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Authors:  Monica Terenziani; Michele Sardella; Beatrice Gamba; Maria Adele Testi; Filippo Spreafico; Gianluigi Ardissino; Fausto Fedeli; Franca Fossati-Bellani; Paolo Radice; Daniela Perotti
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

2.  WT1 mutation and podocyte molecular expression in a Chinese Frasier syndrome patient.

Authors:  Jianguo Li; Dan Zhao; Jie Ding; Huijie Xiao; Na Guan; Qingfeng Fan; Hongwen Zhang
Journal:  Pediatr Nephrol       Date:  2007-08-11       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.